TITLE

Research on human embryonic stem cells

AUTHOR(S)
Powledge, Tabitha M.
PUB. DATE
October 2000
SOURCE
EMBO Reports;Oct2000, Vol. 1 Issue 4, p297
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Calls for the creation of human embryos to use in research would certainly raise hackles, even among those who are well disposed to using surplus embryos. Stem cell transplants from mouse pancreas, for example, have reportedly reversed diabetes in mice. Bone marrow transplants have mitigated the condition of people suffering from lupus and may lead to therapies for other immune system diseases. In fact, although there was some excitement about stem cell research in US financial markets after the guidelines were announced, most of it focused on companies planning to work with adult cells.
ACCESSION #
12956655

 

Related Articles

  • Hitting Rewind. Berg, Thomas // Human Life Review;Spring2006, Vol. 32 Issue 2, p92 

    The article presents a reprint of the article "Hitting Rewind," by Thomas Berg, which appeared in the May 10, 2006 issue of the "National Review Online." It reports on developments in embryonic stem-cell researches in different parts of the world and shows that top stem cell researches supports...

  • Embryo donation for medical research: attitudes and concerns of potential donors. Catherine A. McMahon; Frances L. Gibson; Garth I. Leslie; Douglas M. Saunders; Katherine A. Porter; Christopher C. Tennant // Human Reproduction;Dec2003, Vol. 18 Issue 4, p871 

    BACKGROUND: The recent derivation of embryonic stem cell lines from human blastocysts and related implications for regenerative medicine has intensified a longstanding debate about the use of human embryos for research purposes. However, studies have shown that few couples with stored embryos...

  • The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. Hong Chen; Kun Qian // Human Reproduction;Aug2005, Vol. 20 Issue 8, p2201 

    BACKGROUND: Immune rejection can lead to the failure of human embryonic stem cell (hES cell) transplantation. One approach to address the problem is to establish hES cell line banks. Due to the limited source of human embryos and to ethical reasons, the hES cell lines are not readily available....

  • Embryonic stem cells share immune-privileged features relevant for tolerance induction. Fändrich, Fred; Dresske, Bettina; Bader, Michael; Schulze, Maren // Journal of Molecular Medicine;Jun2002, Vol. 80 Issue 6, p343 

    Continuous immunosuppressive treatment allows the majority of transplant recipients to accept their donated organ and prevent acute graft rejection. However, life-long suppression of the immune system to respond appropriately to infectious, fungal, and carcinogenic threats coincides with...

  • Red gold from stem-cell alchemy. Sobel, Rachel K. // U.S. News & World Report;9/17/2001, Vol. 131 Issue 10, p86 

    Focuses on a report from researchers from the University of Wisconsin on some of the possibilities that may be offered by stem-cells. The privately-funded research that succeeded in getting stem-cells from human embryos to develop into blood-making cells, and red and white blood cells;...

  • Cloning, legislation and human welfare.  // Nature Genetics;Jan2002, Vol. 30 Issue 1, p1 

    Focuses on the controversy surrounding human cloning and stem cell research. Announcement by Advanced Cell Technology that it had produced cloned human embryos for the purpose of deriving stem cells; Risks associated with the U.S. approach to human embryonic stem cell research; Drawbacks of...

  • Close the Door on Cloning. Smith, Wesley J. // Human Life Review;Winter/Spring2002, Vol. 28 Issue 1/2, p132 

    Discusses issues pertaining to the negative aspects of human cloning. Arguments used by proponents of human cloning in order to prove that the human embryo could not be considered as a human life; Effect of the acceptance of cloning on the sanctity of life and the equality of life ethic;...

  • UK cloners target diabetes cure. Coghlan, Andy // New Scientist;8/21/2004, Vol. 183 Issue 2461, p8 

    Great Britain has granted its first licence allowing scientists to try to clone human cells for research. The decision was broadly welcomed, but a few vocal critics denounced the plans as both unethical and unnecessary. In 2001 Great Britain decided to allow therapeutic cloning—producing...

  • Whose eggs?  // New Scientist;11/19/2005, Vol. 188 Issue 2526, p4 

    This article reports that the ethical concerns of a different kind are jeopardising plans for a World Stem Cell Hub to share lines of human embryonic stem cells (ESCs). Plans for the hub were unveiled last month by Woo Suk Hwang of Seoul National University in South Korea, who shot to fame...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics